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Abstract
The cellular arm of the immune response plays a central role in the defense against intracellular pathogens, such as F.
tularensis. To date, whole genome immunoinformatic analyses were limited either to relatively small genomes (e.g. viral) or
to preselected subsets of proteins in complex pathogens. Here we present, for the first time, an unbiased bacterial global
immunoinformatic screen of the 1740 proteins of F. tularensis subs. holarctica (LVS), aiming at identification of immunogenic
peptides eliciting a CTL response. The very large number of predicted MHC class I binders (about 100,000, IC50 of 1000 nM
or less) required the design of a strategy for further down selection of CTL candidates. The approach developed focused on
mapping clusters rich in overlapping predicted epitopes, and ranking these ‘‘hotspot’’ regions according to the density of
putative binding epitopes. Limited by the experimental load, we selected to screen a library of 1240 putative MHC binders
derived from 104 top-ranking highly dense clusters. Peptides were tested for their ability to stimulate IFNc secretion from
splenocytes isolated from LVS vaccinated C57BL/6 mice. The majority of the clusters contained one or more CTL responder
peptides and altogether 127 novel epitopes were identified, of which 82 are non-redundant. Accordingly, the level of
success in identification of positive CTL responders was 17–25 fold higher than that found for a randomly selected library of
500 predicted MHC binders (IC50 of 500 nM or less). Most proteins (ca. 2/3) harboring the highly dense hotspots are
membrane-associated. The approach for enrichment of true positive CTL epitopes described in this study, which allowed for
over 50% increase in the dataset of known T-cell epitopes of F. tularensis, could be applied in immunoinformatic analyses of
many other complex pathogen genomes.
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Introduction
Cell-mediated immunity plays a central role in protection of the
host against pathogens. The major key players of the cellular arm
of the adaptive immune response are CD4+ and CD8+ T-cells,
which recognize pathogenic determinants presented in the context
of MHC molecules on professional antigen presenting cells (APCs).
The contribution of the CD8 response, mediated by cytotoxic T-
cells (CTLs), to protection in the case of intracellular pathogens, is
well documented [1–4]. CTL epitopes are generated from proteins
which are degraded by the proteasome, and are subsequently
transported into the endoplasmatic reticulum (ER) by transporters
associated with antigen processing (TAP), where they are subjected
to further trimming. The binding of the processed peptides (8–11
amino acid in length) to the cleft of the various MHC-I alleles, is
based on sequence features embedded in the peptide sequence and
more specifically in anchor residues [5]. The identification of the
presented MHC-peptide complex by the T-cell receptor triggers a
whole cascade of cellular responses including cell proliferation and
secretion of cytokines (such as IFNc and IL-2).
F. tularensis, a relatively small Gram negative, facultative
intracellular bacterium, is the etiological agent causing tularemia.
The bacterium can infect many animal species, including humans.
The severity of the disease depends on the strain and the route of
infection. Several subspecies are recognized, namely F. tularensis
tularensis (also referred to as type A strains), F. tularensis holarctica
(type B strains), F. tularensis novicida and F. tularensis mediasiatica,
where the two former are documented as human pathogens.
Following inhalation of type A strains a respiratory disease may
develop, which can lead to 30–60% mortality if left untreated [6–
8]. Owing to the low respiratory lethal dose of the type A F.
tularensis isolates and ease of aerosol release, these isolates were
classified as Category A biothreat agents. These facts motivated in
recent years elaborate research efforts aiming at establishing
genetic tools, identification of virulence-related traits and devel-
opment of novel countermeasures [9,10]. Killed vaccines are
highly reactogenic and poorly immunogenic, whereas the live
attenuated LVS vaccine strain (a poorly characterized derivative of
a type B strain) confers partial protection and suffers from side
effects. In the absence of a licensed vaccine, major efforts are
dedicated to the development of a safe and efficacious vaccine
[11–17]. Genomic and proteomic identification of novel targets for
attenuation and/or design of subunit vaccines are currently being
pursued by various approaches. The methodologies underlying
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on the availability of the complete genomic sequence of various
pathogens. Such a ‘‘reverse vaccinology’’ approach was first
applied for Neisseria meningitidis [18] and since then for several other
pathogens [10,19,20–27]. The vital role of cellular immunity in
defense against pathogens resulted in incorporation of the cellular
immunity aspects into reverse vaccinology, sometimes referred to
as ‘‘reverse immunology’’. In parallel, a line of state-of-the-art
computational tools were developed in recent years ([28–30] and
references therein), which produce relatively accurate binding
predictions to many MHC alleles (in particular for MHC class I),
as well as prediction of proteasomal cleavage [31,32] and TAP-
related transport [33]. These methods were validated and proved
to be highly reliable [34–38] and therefore may allow to decipher
the potential repertoire of T-cell epitopes for a given pathogen.
In this study we describe a global immunoinformatic screen
conducted on the genome sequence of F. tularensis LVS strain, in
order to identify putative CTL epitopes and to evaluate their
ability to elicit a T-cell response. In spite of the well acknowledged
and documented contribution of CTLs to protection, the
information on F. tularensis existing CTL epitopes which have
been verified experimentally is very limited. Here we describe a
strategy for whole genome down selection of candidates, based on
mapping of clusters (‘‘hotspots’’) of putative MHC binders. This
whole genome analysis approach was experimentally evaluated on
a total of 1740 putative epitopes, of which 1240 were cluster-based
selected peptides (subset I) and 500 were randomly selected
putative, predicted MHC binders (subset II). The peptides were
synthesized and tested for their ability to induce a CTL response.
The results unequivocally demonstrate the strength of the
developed strategy for enrichment of possible responders among
the in silico candidates mapped from the complete theoretical
bacterial proteome.
Results
Immunoinformatic identification of MHC class I putative
binders
The purpose of the study was to develop a strategy which will
allow for identification of a significant fraction of the effective T-
cell epitope repertoire, in a complete bacterial proteome. The
analysis concentrated on prediction of peptide capability to bind
MHC class I molecules, an event considered as the most selective
in the cascade of events leading to epitope presentation on the
surface of APCs (the analysis did not include the two other
predictable pathway events, namely the proteasomal cleavage step
and TAP binding and transport). The 1754 open reading frame
(ORF) product sequences of F. tularensis can generate over 10
7
possible peptides, 8, 9, 10 and 11-amino acid long. The first step in
the analysis (Figure 1) mapped the putative MHC class I binders to
the various mouse alleles, with predicted binding affinity equal or
higher than 1000 nM. This analysis yielded a pool of 90,879
possible binders (encompassing 79,379 unique sequences) which
originate from almost every ORF product in the genome (1750 out
of 1754). This is still a very large library of possible binders to be
handled experimentally, requiring the development and applica-
tion of a rational strategy for a more rigorous down selection of
candidates towards generation of a subset of peptides for further
experimental evaluation.
Cluster mapping and the selection of putative binders for
experimental evaluation
With the intention to focus on antigen regions with maximal
potential to elicit a CTL response, we decided to search for clusters
of predicted binders along the entire proteome. As an operational
definition, we define a cluster as a succession of at least two
consecutive, overlapping predicted binders, with a maximal length
of 25 amino acids. Accordingly, the minimal length of a cluster can
be 8 amino acids if it contains a 8mer sequence recognizing two
different H2 mouse alleles. Using these boundaries, a total number
of 23,050 clusters could be identified. These contained 86,960
predicted binders, encompassing 75,785 unique sequences origi-
nating from 1736 proteins (Figure 1). Keeping in mind that we
started with 90,879 putative binders, it is quite clear that the
clustering procedure per se is insufficient to significantly reduce the
number of peptides for experimental evaluation. A commonly
used peptide ranking strategy applied for further down selection
relies on binding affinities. However, we decided to undertake a
different approach and to rank these clusters by the density of the
peptides within each cluster (see Materials and Methods; for
example, a density of 1.0 refers to 25 putative binders in a cluster
of 25 amino acids). According to this approach, a versatile cutoff
value for selection could be determined, depending on the size of
the peptide library that one can afford to prepare for experimental
evaluation. To test experimentally our approach, it was decided to
generate a library of 1000–1500 peptides. Accordingly, we found
that the top-ranking 104 clusters (having densities equal to or
greater than 1.0) contain about 1400 peptides. In addition, we
ensured that all 104 clusters include binders predicted to recognize
the MHC alleles of the experimental animal model - C57BL (H2-
Kb and H2-Db). We note that these 104 clusters represent a small
fraction of all 23,050 mapped clusters. Overall, this reductive
strategy (summarized in Figure 1) resulted in a total number of
1240 unique putative CTL epitopes and these peptides constituted
the cluster-based subset of peptides (subset I) for further
experimental evaluation (Table S1).
To test the validity of our approach, we also included a
reference group of predicted MHC binders selected regardless of
their location in clusters. This control group was composed of 500
potential CTL epitopes randomly selected out of the whole
repertoire of predicted binders (Figure 1, subset II), and
encompassing 402 proteins (Table S2). Rather than using the
1000 nM cutoff implemented for subset I, we employed a more
stringent predicted binding affinity cutoff of 500 nM, to increase
the chance of obtaining positive responders in this randomly
selected subset. Aside from this restriction, no other restriction as
inclusion criteria was imposed on the random set. The average
density of clusters in the 402 proteins (0.36) is comparable to the
average density of clusters in the whole genome (0.38). In addition,
as one could expect from a non-biased set, the fraction of binders
restricted to the mouse H2-Kb and H2-Db alleles in the random
set is similar to that in the cluster-based peptide library (77.4% and
82%, respectively; Table S1 and Table S2). The random set of
peptides constitutes therefore a ‘‘naı ¨ve’’ and suitable control set to
evaluate the potential of the cluster-based approach for selection of
putative CTL epitopes. Altogether we synthesized 1740 putative
CTL epitopes for further experimental evaluation.
Antigenicity of the selected peptides
All 1740 potential MHC binders were tested for their ability to
stimulate F. tularensis specific, K
b and D
b-restricted T-cell response.
To this end, groups of C57BL/6 mice were intranasally
immunized with sub-lethal dose of live LVS, splenocytes from
these mice were co-incubated with the individual peptides, and the
extent of stimulation of IFNc production was evaluated in an
EliSpot assay (see Materials & Methods). Two consecutive screens
were performed to identify potential responders: A ‘‘rough’’ screen
followed by a second screen, which was more quantitative
Hotspots of CTL Epitopes in F. tularensis Proteome
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responders in the first screen were further confirmed as positive
also in the second screen. Furthermore, the strong responders in
the first screen ((+++)o r( ++++)), also exhibited the greatest extent
of response in the second screen (30–80 spots/well; Figure 2). A
total of 127 out of the 1240 peptides (10.7%) chosen by the cluster
approach (subset I) were found to stimulate IFNc production from
splenocytes of LVS-immunized mice (Figure 2 and Table S1). In
marked contrast to these results, of the randomly selected 500
potential CTL epitopes (control subset II), only 2 peptides (0.4%)
were found to induce production of IFNc (Figure 2 and Table S2).
Distribution of the parental antigens according to
functional categories
As described earlier, the mapped clusters covered essentially the
entire genome (1736 out of 1754 ORF products). Yet, the top-
ranking 104 clusters selected for analysis of 1240 peptides
represent only 51 ORF products. It was therefore interesting to
determine whether this small number of ORF products populates
functional categories enriched (or under-represented) in compar-
ison to their fraction in the 402 proteins of the random-based set
and to their fraction in the 1754 proteins of the whole genome.
The classification of the proteins into functional categories was
adapted from the CMR database (http://cmr.jcvi.org/tigr-
scripts/CMR/CmrHomePage.cgi), and is presented in Figure 3.
Most interestingly, a strong enrichment of two categories
(Transport and binding proteins and Cell envelope) can be
observed in the subset of 51 ORF products harboring the cluster-
based selected peptides (Figure 3C), as compared to their
frequency in the whole population (Figure 3A) and in the 402
ORF products harboring the random-based selected peptides
(Figure 3B). These two categories are related to the cell membrane
and presumably to membrane-associated proteins. None of the 51
proteins populate functional categories mostly associated with
housekeeping genes, such as protein/amino acid biosynthesis,
DNA and fatty acid metabolism. The percentage of ORF products
Figure 1. Flowchart of the whole-genome immunoinformatic analyses. A schematic representation of the reductive strategy conducted for
down selection of putative MHC binders from the F. tularensis LVS genome and of the cluster based (Subset I) and the randomly chosen (Subset II)
peptide selection for experimental evaluation.
doi:10.1371/journal.pone.0020050.g001
Hotspots of CTL Epitopes in F. tularensis Proteome
PLoS ONE | www.plosone.org 3 May 2011 | Volume 6 | Issue 5 | e20050populating the ‘‘unknown’’ functional category was found to be
lower in the 51 proteins, while for the remaining categories, the
frequency of proteins resembles their relevant frequency in the
whole genome and in the random-based set. The 127 positive
responders were found to be contained in 40 out of the 51 ORF
products. These 40 ORF products exhibit a distribution of
functional categories similar to that of the 51 proteins.
Biochemical characteristics of the parental antigens
The bias toward membrane-associated proteins as CTL peptide
carriers in subset I, and the highly significant percent of responders
within this subset as compared to the randomly selected peptide
binders (subset II), prompted us to analyze the hydrophobicity/
hydrophilicity character of the individual peptides (see Materials &
Methods). The average hydropathy scores of the groups of
peptides belonging to the cluster-based tested set (1240 peptides)
and of the responders group (127 peptides) are 1.86 and 1.66,
respectively. In both groups, the average hydropathy score values
are much higher than the average values of 0.52–0.6 obtained for
either peptides in subset II (the 500 peptides with IC50 values of
500 nM and below), or for the entire population of 90,879
peptides predicted as binders (IC50 values of 1000 nM and below),
or the average values of the peptides considered essentially as non-
binders (IC50.5000 nM). It therefore appears that peptides of
subset I are quite hydrophobic, in accordance with the bias
towards membrane-associated functional categories in the 51
proteins from which these peptides originated (Figure 3). Topo-
logical analysis of the parental antigen sequences for presence of
transmembranal helices revealed that the 51 ORF products indeed
show a strong bias towards integral membrane proteins (65%),
compared to a much lower frequency of 30% in ORFs
encompassing the peptides in the random set (subset II).
Examination of these topological analyses provided some insights
into the characteristics of the cluster regions within these proteins.
In 70% of the cases, the peptides embedded in the cluster regions
were found to co-localize with transmembranal helices and most of
the remaining peptides overlapped with inter-connecting loops.
These profiles are exemplified in Figure 4. We depict two
prototypical membranal polypeptides containing clusters
(Figure 4A and 4C), each cluster within these two polypeptides
harbors about 20 predicted epitopes. For both polypeptides, the
hotspots appear to overlap helical regions, but only in one protein,
two clusters contain CTL responder peptides (Figure 4A). This
example demonstrates that a highly dense cluster overlapping a
helical region is not by itself sufficient to ensure the presence of a
CTL responder. The example shown in Figure 4B demonstrates
co-localization of a hotspot region in a loop between two helices
(such loop region can also be seen in the N-terminal cluster of the
protein presented in Figure 4A). Again, cases of clusters
overlapping loop regions were found also in ORFs that did not
contain any CTL responder (not shown). A total of 26 out of the
51 ORFs containing the high density clusters possess a signal
peptide domain. Yet, only in few of these proteins (4 ORFs) this
signal peptide harbored a cluster of predicted MHC binders.
Figure 2. IFNc EliSpot assay and results of the experimental screens. Sample EliSpot plates from the cluster screen of the 1240 cluster-
derived peptides (left plate) and from the random screen of the 500 randomly selected MHC binders. Each peptide was tested in duplicates; positive
responders are highlighted in red box, while positive and negative control wells are marked by a blue box. (B) Distribution of peptides shown to elicit
IFNc production, according to the extent of their response in the 1
st (‘‘rough’’) and the 2
nd (qualitative) screens. (C) Summary of the total numbers of
tested and responding peptides, in each of the subsets evaluated. The 1240 tested peptides originate from the 104 top-ranking clusters (see Figure 1),
and the 127 responder peptides were found to be located in 86 of these 104 clusters.
doi:10.1371/journal.pone.0020050.g002
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CTL responder peptide (cf. Figure 4D).
Discussion
Unraveling the immune response elicited by a pathogen is of
special significance for deciphering some of the organism routes of
infection and mechanisms of pathogenesis as well as for vaccine
development. Several studies relating to in silico mapping of T-cell
determinants have been described, however these were mainly
reported for individual viral or bacterial proteins, as well as tumor
antigens. More extensive, genome-based screens were conducted
mostly for the relatively small viral genomes. In the case of
complex pathogens, such as for M. tuberculosis and F. tularensis [39–
41], the screens included epitopes from subsets of antigens
preselected according to particular criteria (e.g. secreted antigens).
In view of documented evidence on the involvement of a relatively
large fraction of the genome in the cellular response, it was
recently stated [42] that there is a need for an unbiased analysis of
the whole genome to complement the gap of knowledge that exists
even for extensively studied pathogens, such as Mycobacterium
tuberculosis [43].
Our study focused on CTL epitope analysis of the intracellular
F. tularensis bacterium and to the best of our knowledge, it
represents the first example of a comprehensive whole genome,
unbiased attempt to screen for potential CTL epitopes in a complex
pathogen. The laborious and costly experimental approaches for
evaluation of predicted MHC binders as T-cell epitopes require
the design of a rational filtering strategy, in particular in case of a
bacterial proteome for which a vast number of potential
candidates is generated by the predictions. We show in this study
that a priori mapping of immunological hotspots constitutes an
efficient strategy to enrich the population of responders by
evaluation of a rather small number of potential determinants.
It is well established that there exists an overall correlation
between MHC binding affinity and immunogenicity, where
peptides having an IC50 value of 50 nM and less are considered
as strong binders and IC50 values above 1000 nM are only
occasionally detected. Indeed, studies analyzing the relation
between binding affinities and MHC binding of peptides revealed
that the vast majority of immunogenic peptides have a binding
affinity below 500 nM [44,45,46]. In the present study, the IC50
values assigned to the peptides are theoretical rather than actually
measured, and the mouse alleles under consideration are overall
less represented in the predictor training sets. We therefore
decided to start with a relatively tolerant affinity cutoff of
1000 nM, and to subject the rather large pool of mapped peptides
(a total of 90,879) to additional filtering steps (Figure 1). The
approach we have undertaken is based on identification of
‘‘hotspot’’ regions, namely regions of high density of predicted
MHC binders embedded in stretches of up to 25 amino acids.
Since we limited our analysis to a relatively small library size of
about 1500 peptides, the cutoff of top-ranking clusters was
determined at a density of 1.0 and above. Accordingly, we
selected a pool of 104 top-ranking clusters containing 1240
peptides. This library of peptides was tested for its ability to elicit a
T-cell response in an IFNc-EliSpot assay. It was found that the
majority of the clusters contained one or more positive CTL
epitopes and out of the 1240 tested peptides, 127 were detected as
responders. All 127 epitopes identified in this study are novel F.
tularensis CTL epitopes and none overlap any of the 200
experimentally verified F. tularensis T-cell epitopes compiled from
various studies in the Immune Epitope Database and Analysis
Resource (IEDB, www.immuneepitope.org [47]). Thus by our
approach, we have enlarged the library of F. tularensis T-cell
epitopes by over 50%.
Inspection of the subsets of mapped and evaluated peptides with
respect to their affinities reveals that there is a clear enrichment of
Figure 3. Distribution of F. tularensis proteins according to various functional categories. The classification of the F. tularensis LVS ORF
sequences into the different functional categories was adapted from the CMR database (http://cmr.jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi), with
minor modifications. The population of the proteins in the different categories is presented for the whole genome 1740 ORF products (A), the 402
ORF products containing the 500 randomly-selected putative MHC binders (B) and the 51 ORF products containing all the 1240 tested set of MHC
binders (C). Only functional categories with sufficiently high frequency in the whole genome (over 2%) were included in the chart.
doi:10.1371/journal.pone.0020050.g003
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300 nM) concomitant with the increase in the density of the
parental cluster (Figure 5). While we find it difficult to provide an
explanation for this observation it emphasizes the added value of
focusing on relatively high cluster densities, and it may account, at
least in part, for the observed enrichment of immunogenic
peptides in these highly dense clusters. Yet, we note that due to
our selection strategy, the peptides in the library and the responder
peptides occupy a wide range of predicted affinities, and had we
not included peptides with affinities of 500–1000 nM, we could
have missed 28% of the responders.
Consequential to the selection strategy, a fraction of the selected
peptides as well as the responders are ‘‘nested’’ peptides, and
therefore might, theoretically, stimulate the same T-cell popula-
tion. These nested versions of peptides depend on several events of
degradation that might result in various peptide variations,
including the variation that fits the requirement for protection of
the epitope from peptidase degradation. Inspection of all the 66
sets of nested peptides (overall 166 peptides) among the 1240
cluster-based selected peptides evaluated in this study reveals, that
no rule of thumb (e.g. predicted affinity or peptide length) exists to
decide a priori which among these nested peptides will eventually
elicit the cellular response (see Table S1). In over 50% of the cases
the one peptide within the nested set which eventually elicited the
response was not among the peptides exhibiting the highest
predicted affinity (in ,30% of the cases it had the lowest affinity;
Table S1). Obviously, such nested peptides are scarce in the
random set. Nevertheless, if one would consider only the
‘‘unique’’, non-redundant responders (i.e. any two responder
peptides overlapping by at least 7 residues are suspicious to
stimulate a cross reactive response and therefore counted as one)
then the number of responders should be 82 instead of 127 (Table
S1). Even under such stringent assumptions the extent of response
generated by the cluster approach is 6.6% which is still
significantly high and about 17-fold higher than that found in
the control random set. Deconvolution of the contribution of each
Figure 4. Alignment of ‘‘hotspots’’ of putative CTL epitopes with secondary structure domains. Sample plots of predicted helix-spanning
regions of four selected proteins (graphical presentation of the output generated by TMHMM prediction), aligned with the highly-dense cluster
regions of putative CTL peptides mapped in this study. Briefly, red segments represent the probability of having a helical region, while the thin blue
and pink lines describe a possible topology of the membranal helices. In the lower part of every protein chart, a bar represents a predicted CTL
binder. Co-localization of the putative MHC binders with the predicted helix or loop region in the protein is marked by a grey box. The total number
of predicted CTL epitopes in the hotspot region is given on the rightside of the grey bar, and the stars on the leftside indicate responders. Note, that
in example D, the predicted helix segment overlaps a signal peptide domain, which contains only one out of the three marked responders in the
cluster.
doi:10.1371/journal.pone.0020050.g004
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the subject of future studies.
The most striking observation is that the fraction of immuno-
genic hits obtained among the peptides selected by the cluster-
based approach is 17–25 fold higher than in the case of responders
in the in silico preselected peptides of the random set. The
significance of this result is that the process of selection by highly
dense clusters leads to a substantial enrichment of responders,
without which almost 20,500 to 32,000 putative MHC binder
peptides (instead of the 1240 peptides) would have had to be
screened to identify a similar number of positive responders. It
should be noted though, that the peptides included in the random
set which were selected based on MHC binding alone, were not
the top predicted binding peptides, but rather had overall
comparable affinity to the cluster-based selected peptides.
Therefore, a comparison of our screening strategy (selecting
peptides from hotspots) vs. a conventional screening strategy
(selecting the highest affinity peptides) remains to be done.
Previous reports on hotspot regions of CD8/CTL epitopes (as
well as CD4/HTL epitopes [48,49]) were documented in the
experimental analysis of individual proteins [50–54]. The
tendency of defined CTL epitopes to cluster was detected in the
case of various HIV-1 proteins, and investigation of the amino
acid sequences of some of these protein revealed that the clustered
epitopes are concentrated in relatively conserved regions, an
observation which was proposed by the authors to relate to viral
variation and adaptation to the host. In addition, sites with large
number of overlapping epitopes were found mostly in helical
regions or in loops. Analysis of the CTL clustering in the HIV-1
Nef protein revealed that the sensitivity of hydrophobic regions to
proteasomal processing is the major contributor to the epitope
clustering in such regions [51]. A subsequent, comprehensive
analysis of the HIV proteome corroborated previous findings on
the correlation between epitope-rich regions and hydrophobicity,
however the authors claimed that the predicted CTL epitopes in
HIV-1 are randomly distributed [55]. Our comprehensive,
genome-scale analysis demonstrates a clear enrichment (up to
70%) of membranal proteins containing highly dense regions of
overlapping CTL epitopes. One could suggest that the enrichment
of membranal proteins could be one of the reasons for the high
Figure 5. Distribution of peptide affinities in various pools of predicted MHC binders. The percent of peptides populating a range of
affinities up to 1000 nM is indicated for the following pools: Whole genome (circle) 290,879 peptides; all mapped clusters (star) 275,785 peptides;
clusters with densities up to 0.3 (x sign) 260,870 peptides, up to 0.5 (triangle) 226,699 peptides, up to 0.7 (square) 29,240 peptides, 1.0–1.4
(diamond) 21240 peptides.
doi:10.1371/journal.pone.0020050.g005
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It is important to note that in the control random set, the
proportion of membranal proteins is about 30% (vs. 70% in the
cluster-based set). This observation demonstrates that the
membranal characteristic of the protein may at best account for
2.5-fold enrichment in responders and not to the 17–25 fold
enrichment actually found in the cluster-based set. In addition, we
have also shown that such highly dense preselected regions of
putative epitopes frequently co-localize with hydrophobic regions,
and most explicitly, with the helical segments of the proteins, as
well as loops between helices (Figure 4).
To conclude, we have shown in this study that the strategy of a
priori mapping immunological hotspots can be exploited to cover a
relatively high percent of responders by testing a rather small
number of potential CTL determinants. This approach led to a
major increase (over 50%) in the number of documented T-cell
epitopes of F. tularensis. A relatively high fraction of the determinants
identified in this study are also identical to the orthologous
sequences in the virulent F. tularensis tularensis Schu S4 strain, as
could be anticipated from the extensive sequence identity between
these two strains. Studies are now underway to evaluate the
relevance of some of the responders, and specifically those which
consistently exhibited a high level of stimulation of IFNc
production, for their contribution to protection against the virulent
Schu S4 strain and for design of future vaccines. Finally, we believe
that the application of the approach for enrichment of true positive
responders, as demonstrated in this study, could be of general use
for immunoinformatic analysis of other complex pathogens.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institute of Health. The
protocol was approved by the Israel Institute for Biological
Research Animal Care and Use Committee (Permit Number:
IACUC-IIBR M-53-2009).
Prediction of MHC class I putative binders
A total of 1754 F. tularensis ORF products (holarctica LVS
strain, GenBank accession AM233362) were subjected to analysis
for identification of putative CTL epitopes, by the MHC class I
predictor NetMHC3.0 using artificial neural networks (ANN) [56].
Mouse MHC alleles were considered (H2-Kb, H2-Db, H2-Kd,
H2-Dd). Predicted affinities (IC50, nM) for all 8, 9, 10, 11-mer
peptides were computed. It should be mentioned that apparently,
predictions of 8, 10 and 11-mer Db-restricted epitopes by the
NetMHC3.0 approximation approach might be considered as less
reliable (however in our hands the fraction of Db-restricted
epitopes among the theoretical CTL epitopes and the responders
was similar).
Cluster mapping
A cluster of epitopes was defined as a polypeptide of up to 25
amino acids, containing at least 2 consecutive overlapping
predicted binders. According to this designation, the dataset of
all predicted binders was subjected to cluster mapping, using an in
house developed software package for cluster mapping, data
processing and visualization. The density of a given cluster was
calculated as the number of predicted binders contained within the
cluster divided by its length.
Peptide synthesis
All peptides were synthesized by the 9-fluorenyl-methyloxycar-
bonyl (FMOC) chemistry and validated by mass spectrometry
(Sigma, Israel). Peptides were adjusted to 500 mM stock solutions
and stored at 220uC until use.
Preparation of splenocytes
Animal procedures were approved by the Israel Institute for
Biological Research Animal Care and Use Committee (Permit
Number: IACUC-IIBR M-53-2009). Throughout the experi-
ments, all efforts were made to minimize animal suffering. Groups
of C57BL/6 mice were immunized with 10
2 CFU LVS by the i.n.
route after anesthesia with Ketamine and Xylazine. Six weeks later
mice were euthanized, spleens removed and splenocytes were
prepared using a gentle MACS C-tube (Milteny, Germany)
according to the manufacturer’s instructions. The freshly prepared
splenocytes were suspended in RPMI-1640 supplemented with
10% heat inactivated fetal calf serum and 1 mM of Pen-Strep,
non-essential amino acids, 2 mM L-glutamine and sodium
pyruvate (all tissue culture solutions were obtained from Biological
Industries, Bet Haemek, Israel).
IFNc EliSpot assay
A single-cell suspension of fresh splenocytes was seeded in
EliSpot 96-well plates in complete RPMI medium containing
10 mM of each individual peptide or 10
7 CFU/ml formalin
inactivated LVS as a positive control. Each peptide sample was
tested in duplicates. The frequency of epitope-specific T
lymphocytes was determined using eBioscience IFNc EliSpot kits
with strict adherence to manufacturer’s instructions. In the first
screen (the ‘‘rough’’ screen) we used 10
6 cells per well. A well was
considered to be positive when it contained over 10 spots and had
at least twice the number of spots counted in the negative control
well. Throughout the screen, the background number of spots in
negative control wells did not exceed five spots per well. The
second screen (a more quantitative screen) included only the
positive peptides from the first screen and contained less cells per
well (5610
5 cells per well), which allowed a more accurate
quantification of the results. In this second screen, the background
number of spots in negative control wells was 0–1 and the number
of spots among the positive peptide responders was at least 7.
Throughout the experiment, the positive control (inactivated LVS)
was confluent. Eventually, all of the responses that were
considered positive according to the mentioned criteria were also
positive by the two-tailed non-parametric Mann–Whitney U-test
(at p,0.05).
Transmembranal helices and signal peptide predictions
Analysis of membrane protein topology was conducted by the
program TMHMM v2.0 [57] for prediction of transmembranal
helices based on hidden Markov model. Analysis of proteins for
presence of a signal peptide domain was performed by the Signalp
3.0 server, using the Neural networks (NN)-based method [58].
Hydropathy score calculation
The hydropathicity of a peptide was calculated by an in-house
script based on the GRAVY value (ExPASy Proteomics Server,
http://expasy.org/tools/protparam-doc.html) defined as the sum
of hydropathy scores of all its amino acids divided by the number
of residues in the sequence. The scores are based on the amino
acid indices derived by Kyte and Doolittle [59].
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Table S1 List of 1240 peptides selected by the cluster-based
approach. The affinity provided is the value predicted for a
particular responder sequence by the NetMHC3.0 program.
Cluster density is the number of predicted CTL epitopes in the
responder parental cluster, divided by the parental cluster length.
The gi number and annotation of the source protein are according
to the F. tularensis holarctica LVS sequence deposited at the NCBI
(GenBank accession AM233362);
(a) Magnitude of T-cell response
for each identified epitope is indicated as follows (expressed in
SFC/million cells): L (low) - 7–19; M (medium) - 20–34; H (high) -
35 and above.
(PDF)
Table S2 List of 500 peptides selected by the random-based
approach. The affinity provided is the value predicted for a
particular responder sequence by the NetMHC3.0 program.
Cluster density is the number of predicted CTL epitopes in the
responder parental cluster, divided by the parental cluster length.
The gi number and annotation of the source protein are according
to the F. tularensis holarctica LVS sequence deposited at the NCBI
(GenBank accession AM233362);
(a) Magnitude of T-cell response
for each identified epitope is indicated as follows (expressed in
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